Geneva (July 2, 2025) – SGS, the world’s leading testing, inspection and certification company, is pleased to announce a complimentary webinar titled ‘Biocompatibility Testing – In Vitro and Animal Alternative Tools for ISO 10993 Evaluations’, taking place on July 15, 2025.
With regulatory authorities placing growing emphasis on biological safety, medical device manufacturers must now provide clear, risk-based biocompatibility evidence aligned with ISO 10993 requirements, within the broader context of ISO 14971 risk management. Foundational tests for cytotoxicity, sensitization and irritation remain critical components of any compliant biological evaluation strategy.
In this live webinar, SGS experts Bruce Yang, Toxicologist, and Sebastien Vogel, Customer Service Group Leader, will share practical insights and regulatory strategies for designing and implementing biocompatibility plans that meet current regulatory expectations. Topics will include risk assessment design, test selection, sample preparation, extraction protocols and advances in animal-alternative testing.
The session will focus on in vitro testing capabilities under ISO 10993-5, -12 and -23, and is ideal for professionals in medical device R&D, manufacturing, quality or regulatory affairs, especially those involved in biocompatibility testing or managing products with biological safety considerations.
Following the presentation, attendees will have the opportunity to ask the experts specific questions related to their products and testing strategies.
For further information, please contact:
Jennifer Buckley
Senior Global Marketing Manager
Health & Nutrition
Tel: +1 973 461 1498
About SGS
SGS is the world’s leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of 99,500 dedicated professionals. With over 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability.
Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and trusted specialized brands, including Brightsight, Bluesign, Maine Pointe and Nutrasource.
SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN:SW).